ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Chemoradiotherapy Followed by Surgery for Advanced Paranasal Sinus Cancer

This study is not yet open for participant recruitment.
Study NCT00347256.   Last updated on June 29, 2006.   Information provided by University of Tennessee

This Tabular View shows the required WHO registration data elements as marked by

Descriptive Information Fields
Brief Title  Chemoradiotherapy Followed by Surgery for Advanced Paranasal Sinus Cancer
Official Title  Preoperative Radiotherapy and Concomitant Chemotherapy Followed by Surgery for Advanced Paranasal Sinus Carcinoma
Brief Summary

The purpose of this study is to determine the efficacy of concurrent chemotherapy and radiotherapy pre-operatively in patients with advanced paranasal sinus cancer. The main objectives of this study are: 1) to measure the rate of complete response to preoperative chemoradiation and 2) to study the efficacy of combining preoperative chemoradiation and surgery in terms of local control of the cancer two years post treatment.

Detailed Description
Study Phase
Study Type  Interventional
Study Design  Treatment, Non-Randomized, Open Label, Historical Control, Single Group Assignment, Safety/Efficacy Study
Primary Outcome Measure  Local control of cancer at two years post treatment
Response to preoperative chemoradiation
Secondary Outcome Measure  Estimation of the proportion of the inoperable tumors which become operable after chemoradiation
Identification of factors that are associated with inoperability
Estimation of the overall survival and cumulative incidence of death due to disease at 2 years
Determination of the acute and long-term toxicity, particularly ophthalmologic complications, and surgical morbidity associated with this regimen
Measurement of the accuracy of conventional imaging techniques (CT, MRI) compared with the addition of PET imaging in predicting the response to chemoradiation therapy.
Condition  Paranasal Sinus Neoplasms
Intervention  Drug: cisplatin
Procedure: targeted radiation therapy
Procedure: tumor resection
MEDLINE PMIDs
Links North American Skull Base Society webpage This link exits the ClinicalTrials.gov site
Recruitment Information Fields
Recruitment Status  Not yet recruiting
Enrollment  60
Start Date 
Completion Date
Eligibility Criteria 

Inclusion Criteria:

  • Karnofsky Performance Score: >= 60
  • Creatinin clearance >= 50 ml/min or serum creatinine =<1.5 mg/dl
  • Total bilirubin, AST, ALT =< 1.5 X laboratory uln
  • ANC >= 2000/mm3, platelets >= 100,000/mm3
  • Serum calcium within normal range
  • T3 or T4 state tumors of paranasal sinuses
  • Squamous cell carcinoma, adenocarcinoma, high-grade mucoepidermoid carcinoma, sinonasal undifferentiated carcinoma

Exclusion Criteria:

  • History of other malignancy in the last 3 years
  • Other serious comorbidity that may significantly reduce the survival in next 5 years
  • Pregnant or lactating women
  • History of radiation to the head and neck region
  • Paranasal sinus tumor is recurrent after prior treatment
  • Presence of cervical node metastasis
  • Presence of distant metastasis
  • Advanced nasopharyngeal malignancy with sphenoid or posterior ethmoid invasion
Gender Both
Ages 18 Years and older
Accepts Healthy Volunteers No
Contacts ††
Contact: Sandeep Samant     901-448-5885     ssamant@utmem.edu    
Contact: Priscilla Adler     901-516-2763     padler@utmem.edu    
Location Countries  United States
Administrative Information Fields
NCT ID  NCT00347256
Organization ID NASBS-PNS001
Secondary IDs ††
Study Sponsor  University of Tennessee
Collaborators †† North American Skull Base Society
Investigators 
Study Chair:     Sandeep Samant, MS, FRCS     University of Tennessee Health Science Center    
Principal Investigator:     Sandeep Samant, MS, FRCS     University of Tennessee Health Science Center    
Information Provided By University of Tennessee
Verification Date June 2006
First Received Date  June 29, 2006
Last Updated Date June 29, 2006

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.




Links to all studies - primarily for crawlers